Gliomas express a higher amount of Fas than normal brain tissue. It is of interest to know whether expression of the Fas receptor is unfavorable to the antiapoptotic pathways in gliomas. In this study, we introduced the Fas gene via an adenovirus vector (Adeno-Fas) into the A-172, U251, and U-373 MG glioma cell lines, each of which expresses Fas on the cell surface. Infection of Adeno-Fas induced apoptosis in each glioma cell line. In U251 cells and A-172 cells that express the same level of Fas as a result of infection with Adeno-Fas, a much higher percentage of U251 cells underwent apoptosis than did A-172 cells. This suggests that each glioma cell line has its own threshold of Fas expression, above which apoptosis is induced, and that the constitutive expression of Fas is below the level of this threshold. It was found that the constitutive expression of the anti-apoptotic gene Bcl-X L is higher in A-172 cells than in U251 cells. Adenovirus-mediated transduction of the Bcl-X L gene into U251 cells effectively suppressed Adeno-Fas-mediated apoptosis. These data indicate that the Bcl-X L gene is one of the important determinants of the threshold for Fas-mediated apoptosis. When U251 and U-373 MG cells were transduced with the Fas gene controlled by the myelin basic protein promoter, which had been shown to be active in gliomas but not in neural tissues, the cells underwent markedly enhanced apoptosis. Taken together, these results indicate that the overexpression of Fas alone induced apoptosis in each glioma cell line. The degree of Fas-mediated apoptosis was attenuated by the expression of an anti-apoptotic gene, Bcl-X L . The adenovirus-mediated induction of Fas gene controlled by a tissue-specific promoter (e.g., myelin basic protein promoter) would be a promising therapeutic approach for malignant glioma. Cancer Gene Therapy (2000) 7, 224 -232
I
t is thought that the balance between pro-and antiapoptotic proteins is upset in cancer cells, and that the balance is generally in favor of cell death blockers, which cause resistance to apoptosis. 1, 2 However, the death signal receptor Fas(APO-1/CD95), which mediates apoptosis by a signal from Fas ligand (FasL) or anti-Fas antibody (Ab), 3 could also be involved in the malignant progression of cancers. 4 The degree to which Fas is expressed in cancer cells varies among different types of cancer. The malignant progression of gliomas is accompanied by an increased expression of Fas. 5 Fas engagement enhances the growth of some cancers, 6 suggesting that a higher expression of Fas in gliomas might facilitate their growth. Alternatively, the overexpression of Fas may provide the apoptotic signal in gliomas. 7 To our knowledge, there have been no reports regarding whether an overexpression of Fas alone induces apoptosis of cancer cells. Thus, it is of interest to investigate the apoptosis of gliomas transduced with the Fas gene.
In previous studies, we introduced the Fas gene into U251 glioma cells via retrovirus and obtained U251 transfectants; these transfectants displayed a high level of expression of Fas but did not show the phenotype of apoptosis, probably because we had selected clones that have a high constitutive expression of anti-apoptotic proteins, which inhibit apoptosis in such transfectants.
transfer of the Fas gene under the control of the myelin basic protein (MBP) promoter 9 -11 induces apoptosis in gliomas. We found that overexpression of Fas alone induced apoptosis in each glioma cell line, suggesting that tissue-specific induction of Fas through an adenoviral vector is a promising therapeutic approach for gliomas. Each glioma had a different threshold of Fas expression that induced Fas-mediated apoptosis. Moreover, Bcl-X L was found to be a key molecule that represses Fas-induced apoptosis.
MATERIALS AND METHODS

Cell lines
Three glioma cell lines were analyzed. These were A-172, U-373 MG (obtained from American Type Culture Collection, Manassas, Va), and U251 (obtained from the Tumor Registry, Division of Cancer Treatment, National Cancer Institute, Frederick, Md). All of the glioma cell lines were maintained in Dulbecco's modified Eagle's medium (Nissui Pharmaceutical, Tokyo, Japan), which contains 10% fetal bovine sera, 0.2% sodium bicarbonate, 2 mM glutamine, 100 U/mL penicillin, and 100 g/mL streptomycin.
Generation of recombinant adenoviral vectors
The cDNAs of human Fas (hFas) were cloned by reverse transcription-polymerase chain reaction using template crude RNA from human THP1 cells (no. TIB-202, American Type Culture Collection) and the following primers: 5Ј-CCGAAT-TCTCGAGCACCATGCTGGGCATCTGGACCCTC3-Ј and 5Ј-CCGAATTCTAGACCAAGCTTTGGATTTCATTTCTG-AAGTTTGA-3Ј. The cDNA clone was sequenced and confirmed to be identical with the reported sequence (GenBank accession no. M67454). The ϳ1.1-kb EcoRI fragment of Fas cDNA was inserted into pBluescript KS ϩ (Stratagene, La Jolla, Calif), which generated pKS ϩ hFas. The ϳ1.1-kb EcoRI fragment of Fas cDNA from pKS ϩ hFas was inserted into the EcoRI site of pCAcc 12 to generate pCAcc-hFas. The pAxCAhFas cosmid was constructed by inserting the ϳ3.3-kb ClaI expression cassette of pCAcc-hFas into the ClaI site of the cosmid pAxcw. 13 The ϳ1.0-kb EcoRI blunted fragment of hFas cDNA from pCAcc-hFas was inserted into the SwaI site of pAxCALNLw 14 to generate pAxCALNL-hFas. The cDNA of human Bcl-X L (hBcl-X L ), which was provided by Dr. Boise (Chicago, IL), 15 was inserted into the EcoRI/ EcoRI site of pCAcc to generate pCAcc-hBcl-X L . The ClaI expression cassette of pCAcc-hBcl-X L was ligated to the ClaI site of the cosmid pAxcw, resulting in the cosmid pAxCA-hBcl-X L .
The cosmids were cotransfected with the DNA-terminal peptide complex of adenovirus type 5, and recombinant adenoviruses were generated as described by Miyake et al. 13 We used a 293 subclone, 293/CrmA, which had been transduced with the caspase-resistant CrmA gene, as the host cell to generate the AxCA-hFas adenovirus. 16 Details of the generation of the 293/CrmA cells are described elsewhere. 16 The recombinant adenovirus AdexMBP-NL-Cre carries the Cre recombinase gene 17 with a nuclear localization signal under the control of the mouse MBP promoter (ϳ1.3 kbp from the BglII site at nucleotide Ϫ1297 to the AccIII site at nucleotide ϩ34 relative to the transcription start position at nucleotide ϩ1). 11, 18 Because the transduction efficiency of the adenovirus vector for lacZ along with AdexMBP-NL-Cre was much higher compared with that of the adenovirus vector for lacZ directly controlled by the MBP promoter, we used AdexMBP-NL-Cre for the specific expression of Fas in glioma cells (unpublished observations). The details of the generation of AdexMBP-NLCre will be described elsewhere (unpublished observations).
Adenovirus-mediated gene transduction was performed according to the method described by Yoshida and Hamada. 12 Staining with 5-bromo-4-chloro-3-indoyl ␤-D-galactopyranoside was performed as described previously. 12 AxCALNL-hFas was always coinfected with AdexMBP-NL-Cre at one-fifth the multiplicities of infection (MOIs) of AdexMBP-NL-Cre.
Assessment of apoptosis and cell death
The cancer cells were infected with various MOIs of AdenoFas or Adeno-Bcl-X L with a combination of Adeno-Fas and Adeno-Bcl-X L . In each set of experiments, the total MOI of the adenovirus, which was supplemented with adenovirus vector for lacZ (Adeno-lacZ) 12 was kept at a constant. Assays of apoptosis were performed at 72 hours postinfection.
The degree of apoptosis was measured by quantifying the degree of DNA fragmentation (hypoploidy) using a modification of the method described by Telford et al. 19 The adherent cancer cells were trypsinized, combined with the detached cells in the supernatant, washed twice with phosphate-buffered saline (PBS), and resuspended in 100% ethanol. After gentle mixing for 30 minutes at room temperature, the cells were washed twice with PBS, followed by incubation with 2 mg/mL ribonuclease for 30 minutes. After centrifugation at 140 ϫ g for 5 minutes at 4°C, the pellet was resuspended in 0.05 mg/mL propidium iodide (PI) and mixed gently for 20 minutes at room temperature. The samples were analyzed with CellQuest software on a FACScan (Becton Dickinson, San Jose, Calif). The DNA fluorescence gate was set up to exclude cell aggregates and debris, and the percentage of cells that underwent apoptosis was assessed to be the percentage of the area of fluorescence in which the fluorescence was smaller than the G 0 /G 1 peak out of the total area of fluorescence. The normal range of hypoploidy in nontreated cells was usually ϳ5% or less.
For transmission electron microscopy, cells infected with Adeno-Fas at an MOI of 100 were fixed overnight at 4°C in 0.1 M sodium phosphate buffer (pH 7.5) containing 2.5% glutaraldehyde, fixed in 0.1 M sodium phosphate buffer (pH 7.2) containing 1% OsO 4 , and embedded into epon 812 (Taab, Berkshire, UK). Ultrathin sections were contrasted with uranyl acetate and lead citrate and examined with a H7000 transmission electron microscope (Hitachi, Tokyo, Japan).
The DNA fragments in apoptotic cells were detected using the APO-BRDU TM kit (PharMingen, San Diego, Calif) according to the manufacturer's instructions. Briefly, the 3Ј-hydroxyl ends of DNA in apoptotic cells were labeled with bromolated deoxyuridine triphosphate nucleotides (Br-dUTP) by terminal deoxynucleotidyl transferase, and Br-dUTP was stained by a fluorescein isothiocyanate-labeled anti-bromodeoxyuridine monoclonal Ab (mAb). The samples were stained with PI and analyzed by fluorescence-activated cell sorting (FACS). The assay was performed 3 days after infection with adenovirus.
To determine the percentage of cells that had died, the cells that had adhered to the plate and those that had detached from the plate were stained with 0.2% trypan blue; next, they were counted using a hemocytometer. The assay was performed 3 days after infection with adenovirus.
Detection of Fas
FACS analysis of Fas expression on the cell surface was performed as described previously. 8 Briefly, one million cells were incubated with 0.25 g of fluorescein isothiocyanateconjugated mouse anti-human CD95 Ab (no. 33454X, PharMingen) for 20 minutes at 4°C, washed twice, resuspended in PBS with 5% fetal bovine serum, and analyzed by FACScan using CellQuest software according to the manufacturer's instructions (Becton Dickinson). An isotype-matched control Ab was used for negative control staining. To evaluate the expression of Fas induced by infection with adenovirus for the Fas gene under the control of MBP promoter (Adeno-MBPFas), FACS analysis was performed at 48 hours postinfection.
Immunoblot analysis of cell lines
Immunoblot analysis of Bcl-X L and Bcl-2 expression was performed as described previously. 8 Briefly, after extraction of protein with 8ϫ lysis buffer (10 mM tris(hydroxymethyl)aminomethane (Tris)/HCl (pH 8.0), 0.2% Nonidet P-40, and 1 mM ethylenediaminetetraacetic acid), equal amounts of protein from each extract (20 g/lane) were separated using 12% polyacrylamide gels and transferred onto nitrocellulose membranes. After blocking with 5% dry milk in Tris-buffered saline (10 mM Tris-HCl (pH 7.5), 150 mM sodium chloride), the membranes were incubated with primary Ab overnight at 4°C. We used rabbit anti-human Bcl-X polyclonal Ab (no. B22630, Transduction Laboratories, Lexington, Ky) and mouse antihuman Bcl-2 mAb (no. sc-509, Santa Cruz Biotechnology, Santa Cruz, Calif). After washing, the membranes were incubated with 30 L (per 15 mL) of horseradish peroxidaseconjugated donkey anti-rabbit immunoglobulin G (F(abЈ) 2 ) (Amersham, Buckinghamshire, UK) for Bcl-X L and with rabbit anti-mouse immunoglobulin G plus AϩM(HϩL) (no. 61-6420, Zymed, San Francisco, Calif) for Bcl-2, using an enhanced chemiluminescence kit according to the manufacturer's instructions (Amersham). The intensities of the bands in immunoblots were analyzed using a densitometer (Atto Densitograph, Atto, Tokyo, Japan).
RESULTS
Apoptosis of gliomas induced by Adeno-Fas
To investigate whether overexpression of Fas induces apoptosis in gliomas, each glioma cell line was infected with Adeno-Fas or Adeno-lacZ at various MOIs. At 72 hours postinfection, the degree of apoptosis in each cell line was assayed by FACS. The construct of Adeno-Fas is shown in Figure 1A . The gene transduction efficiency of Adeno-lacZ differs in each of the three glioma cell lines (Fig 1B) . Although A-172 cells showed the lowest transduction efficiency among these three lines at an MOI of 300, Ͼ75% of the A-172 cells were successfully infected with Adeno-lacZ. This indicates that all of the tested glioma cell lines are susceptible to adenovirus infection. To determine the relationship between the level of expression of surface Fas and susceptibility to Adeno-Fas-mediated apoptosis, the expression of surface Fas was analyzed by FACS after infection with Adeno-Fas at various MOIs. The expression of surface Fas increased in an MOI-dependent manner in each cell line (Fig 2) .
The induction of Fas in gliomas led to apoptosis. Also, the glioma cells did not receive any apoptotic signal, such as from recombinant FasL or anti-Fas Ab. The degree of apoptosis induced by Adeno-Fas differed among the glioma cell lines (Fig 3) . In U251 cells, Adeno-Fas induced apoptosis very effectively. When Adeno-Fas was transfected into U251 cells at MOIs of 30 and 300, the percentage of cells that had undergone apoptosis at 72 hours postinfection was 42 Ϯ 2% and 88 Ϯ 4%, respectively (Fig 3) . Transmission electron microscopy of U251 cells examined at 72 hours after infection with Adeno-Fas exhibited the typical ultrastructural features of apoptosis (Fig 4) . Many cells were in various stages of the apoptotic process. Some cells were characterized by condensation of the heterochromatin (Fig 4A) , and other cells showed fragmentation of the heterochromatin and cytoplasm to form apoptotic bodies (Fig 4B) . It is of note that infection with the adenoviral vector used in this study did not affect Fas expression on the surface of infected cells due to the deletion of the E3. 20 A higher percentage of glioma cells underwent apoptosis as the MOI at which Adeno-Fas was transfected was increased (Fig 3) . However, in clear contrast to the drastic apoptosis of U251 cells, apoptosis was not induced effectively by Adeno-Fas at an MOI of as high as 300 in A-172 cells. At an MOI of 300, the percentage of cells that had undergone apoptosis at 72 hours postinfection in the A-172 cell line was 5.5 Ϯ 0.4% (Fig 3) . Thus, infection of A-172 cells with Adeno-Fas at MOIs of up to 300 enhanced apoptosis slightly. The MOI of adenovirus vector needed to achieve a similar level of transgene expression varies among different cell lines (Fig 1B) . An MOI of 30 for the U251 cell line and an MOI of 100 in the A-172 cells was required to achieve a similar level of expression of Fas in these two cell lines (peak 5 in left panel of Fig 2, peak 6 in middle panel of Fig 2) . In contrast to A-172, the percentage of U251 cells transfected with Adeno-Fas at an MOI of 30 that had undergone apoptosis at 72 hours postinfection was 42 Ϯ 2% (Fig 3) . Thus, even when the U251 cells and A-172 cells expressed the same level of Fas, the percentage of Moreover, although U-373 MG cells showed higher surface Fas expression than U251 cells after infection with Adeno-Fas at the same MOI (Fig 2) , the percentage of hypoploid U373 MG cells at 72 hours after Adeno-Fas infection was approximately one-third the percentage of hypoploid U251 cells (Fig 3) . These results indicate that the level of Fas expression does not have a direct correlation with the degree of apoptosis caused by Fas overexpression. Thus, each individual cell line has its own threshold of Fas expression, above which apoptosis is induced. It appears that the constitutive level of expression of Fas in gliomas is set below the respective threshold, as the control glioma cell lines without Adeno-Fas treatment did not show significant apoptosis.
Expression of anti-apoptotic genes and correlation with anti-apoptotic function
Because A-172 cells require a higher level of Fas expression to induce apoptosis than do U251 cells, we postulated that the constitutive expression of anti-apoptotic Figure 4 . Morphology of apoptosis of U251 cells as viewed by transmission electron microscopy. U251 cells were infected with Adeno-Fas (MOI of 100). After 72 hours, they were prepared for viewing under an electron microscope as described in Materials and Methods. A: Condensed heterochromatin being expelled from cells can be seen (original magnification at ϫ7000). B: Fragmented cytoplasm being packaged into apoptotic bodies can also be seen (original magnification at ϫ10,000). genes determines the threshold level of Fas expression above which apoptosis is induced. To test this possibility, we examined the expression of Bcl-X L and Bcl-2 in each glioma cell line by immunoblot analysis (Fig 5) . The constitutive expression of Bcl-X L in A-172 cells ( Fig  5A-a, lane 1 ) was much higher (over three times higher by densitometer analysis), than that in U251 cells ( Fig  5A-a, lane 2) . The constitutive level of expression of Bcl-X L in U-373 MG cells was at an intermediate level between that in A-172 cells and that in U251 cells. This observation corresponds to the finding that Adeno-Fas induced a level of apoptosis in U-373 MG cells that was between the level of apoptosis induced in A-172 cells and that induced in U251 cells. To determine whether a high level of expression of Bcl-X L represses the apoptosis induced by the overexpression of Fas, we compared the level of apoptosis induced by Adeno-Fas infection alone with that induced by simultaneous infection of Adeno-Fas and Adeno-Bcl-X L in U251 cells. Overexpression of Bcl-X L markedly suppressed Adeno-Fasinduced apoptosis from 81% to 0.1% (Fig 5B) . These data indicate that Bcl-X L plays an important role in determining the threshold of Fas expression above which Fas-mediated apoptosis is induced in glioma cell lines. Alternatively, the constitutive expression of Bcl-2 was much lower in A-172 cells (Fig 5A-b, lane 1) (less than one-tenth by densitometer analysis) compared with U251 cells (Fig 5A-b, lane 2) . (Fig 6C) , as well as fragmented DNA in both cells (Fig 6D) . The degree of apoptosis in U-251 cells was more remarkable compared with that in U-373 MG cells. The results indicate that Adeno-MBP-Fas induces apoptotic cell death quite effectively in glioma cells.
DISCUSSION
In this study, the induction of apoptosis as mediated by infection of the adenoviral vector for Fas was investigated. A-172, U251, and U-373 MG glioma cells constitutively expressed FasL protein and mRNA at low levels, if at all, as described previously. 8 Therefore, apoptosis was induced by overexpression of the Fas receptor without a signal from FasL or anti-Fas Ab. To our knowledge, this is the first report that describes apoptotic cell death caused solely by overexpression of the Fas receptor independent of FasL and anti-Fas Ab. The genes that encode the tumor necrosis factor (TNF) receptor and the Fas receptor have structurally related motifs in the intracellular domains (death domain) 21 and self-associate mainly through these domains. 22 It has been demonstrated in HeLa cells that merely increasing the expression of the p55 TNF receptor and, in particular, its intracellular domain, resulted in cell death by self-association. 22 In our study, adenovirus-mediated overexpression of the Fas receptor most likely induced self-association and triggered the signaling for cytotoxicity. The self-activation of pro-apoptotic proteins caused by their overexpression has been also reported in caspase-8 23 and Fas-associated death domain protein (FADD). 24 When the proenzyme molecules of caspase-8 are approximated, they process themselves into its active protease form. 23 Similarly, the overexpression of FADD in MCF7 and BJAB cells induced apoptosis. 24 Thus, apoptotic pathways of cancers can be activated solely by the overexpression of a Fas-related gene; such genes include the Fas receptor, TNF receptor, FADD, and caspase-8.
Malignant gliomas have a high constitutive level of expression of Fas. 5 Anti-Fas-mediated growth stimulation has been reported in solid tumor cell lines 6 and in chronic B-lymphocytic leukemia. 25 This suggests that the expression of Fas may facilitate the growth of gliomas. However, as shown in this study, the overexpression of Fas induced apoptosis in gliomas. This indicates that there are cellular mechanisms that prevent the constitutive Fas-mediated apoptotic signal. 26 The degree of Adeno-Fas-induced apoptosis was not linked to the degree of Fas expression in gliomas. Accordingly, each glioma cell line has its own threshold of Fas expression, above which apoptosis is induced, and the constitutive level of Fas expression was kept below the threshold level.
Which gene determines the threshold of Fas expression, above which apoptosis is induced? Whereas the investigation of the role of various cell death repressors, such as FAP-1, 27 FLAME-1, 28 and FLIP, 29 in cancers remains as a future project, the roles that Bcl-2 family genes play in oncogenesis and in the malignant progression of cancers have been investigated in detail. 30 Therefore, in this study, we analyzed the expression and function of Bcl-2 family genes in glioma cell lines. There was a correlation between the constitutive level of expression of Bcl-X L and the degree to which Fasmediated apoptosis was inhibited (Figs 3 and 5A) . However, no correlation was found between the level of expression of Bcl-2 and the degree of Adeno-Fas-mediated apoptosis (Figs 3 and 5A) . Induction of Bcl-X L markedly repressed Adeno-Fas-mediated apoptosis ( Fig  5B) . Clinical studies have reported that the level of Bcl-2 expression did not correlate with the malignant progression of gliomas. 31, 32 However, 98% of gliomas expressed Bcl-X L . 33 It has been assumed that Bcl-X L plays a critical role in protecting brain tissue from injury and hypoxia. 34 In other cancers, such as Kaposi's sarcoma, 35 gastric carcinoma 36 and leukemia, 37 Bcl-X L was preferentially expressed compared with Bcl-2. Although further studies using many clinical samples will be required to elucidate the general role that Bcl-2 family proteins play in gliomas, the previous findings are in accord with our findings in that Bcl-X L is one of the critical determinants of the susceptibility of gliomas to apoptosis.
Concerning clinical trials of the gene therapy of malignant gliomas, retroviral vectors have a low transduction efficiency, resulting in insufficient killing of glioma cells. 38 Adenoviral vectors have a much higher transduction efficiency than retroviral vectors. 8 Therefore, adenovirus-mediated transfer of an apoptosis-related gene will be a useful tool to investigate the gene therapy of gliomas. The level of expression of caspase-3, a pro-apoptotic molecule downstream of Fas, is low in neurons. 39 Neurons also do not express Fas. 40 Thus, neurons should be resistant to Fas-mediated cell death. 40 Therefore, selective overexpression of the Fas gene in tumor cells, for example by using MBP promoter in this study, could be a promising approach for gene therapy of malignant gliomas, sparing damage to normal brain tissue. This MBP promoter is specific for oligodendrocytes in vitro and in vivo. 11 In glioma cells, the MBP promoter was more active than the promoter of glial fibrillary acidic protein (data not shown; see also Refs. 9 and 10). As anticancer drugs (e.g., cisplatin) augment the susceptibility of cancer cells to Fas-mediated apoptosis, 41 the combined usage of anticancer drugs together with Fas genetic transduction could be a useful approach to render apoptosis-resistant cells sensitive. Because it has been reported that overexpression of p53 enhances the expression of Fas, 42, 43 the combined overexpression of p53 and Fas on apoptosis-resistant glioma cells may have a potent therapeutic effect.
In conclusion, introduction of the Fas gene into gliomas via adenovirus provides an important clue, not only for understanding the mechanisms involved in the malignant progression of gliomas, but also for the application in gene therapy.
